The EFPIA Disclosure Code provides a common basis for reporting across Europe in relation to transfers of value. For more information on this Code visit: http://transparency.efpia.eu/ or http://www.siffa.lv/uploads/etika/Kodeksi_2014/Kodeksi_JN/EFPIA_Disclosure_140919.pdf
The publication of this information is made for transparency purposes only, as further detailed in the Pfizer EEA HCP Privacy Policy at https://privacycenter.pfizer.com/en/hcp-lv (section “Disclosures of transfer of value”). It does not entail a general authorisation to those accessing the website to carry out any further processing of health care professionals' (HCP’s) data, such as combining it with the information published on other websites.
According to the SIFFA and LPMA Code of Good Practice and Ethics (effective as of December 01, 2020) in Latvia reports about the Transfer of Values (ToVs) made to HCPs and HCOs during the year 2020 are submitted by the company to the Health Inspectorate and will be available on the following site www.vi.gov.lv by 30 June, 2021
According to the SIFFA and LPMA Code of Good Practice and Ethics (effective as of December 01, 2020) in Latvia reports about the Transfer of Values (ToVs) made to HCPs and HCOs during the year 2021 are submitted by the company to the Health Inspectorate and will be available on the following site www.vi.gov.lv by 30 June, 2022
2021 report of values transferred to POs can be found here.
Pfizer Self Certification Scheme for 2021 can be found here.
According to the SIFFA and LPMA Code of Good Practice and Ethics (effective as of December 01, 2020) in Latvia reports about the Transfer of Values (ToVs) made to HCPs and HCOs during the year 2022 are submitted by the company to the Health Inspectorate and will be available on the following site www.vi.gov.lv by 30 June, 2023
2022 report of values transferred to POs can be found here.
Pfizer Self Certification Scheme for 2022 can be found here.
Last Review date: June 2020